Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: A prospective, hypothesis driven study on patients with locally advanced rectal cancer

Radiotherapy and Oncology

Volumn 111, Issue 2, 2014, Pages 237-242

  Buijsen, Jeroen ^a   Van Stiphout, Ruud G ^a   Menheere, Paul P C A ^b   Lammering, Guido ^a   Lambin, Philippe ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood biomarkers; Chemoradiation; Rectal cancer; Response prediction

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CA 19-9 ANTIGEN; CALCIFEDIOL; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; OSTEOPONTIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; TREATMENT RESPONSE; BLOOD; CANCER STAGING; CHEMORADIOTHERAPY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RECTAL NEOPLASMS; REPRODUCIBILITY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CHEMORADIOTHERAPY; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OSTEOPONTIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84902540149     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.03.006     Document Type: Article

References (24)

1. V. Valentini, C. Aristei, and B. Glimelius et al. Multidisciplinary rectal cancer management: 2nd European rectal cancer consensus conference (EURECA-CC2) Radiother Oncol 92 2009 148 163
2. M. Maas, P.J. Nelemans, and V. Valentini et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
3. L. Zorcolo, A.S. Rosman, and A. Restivo et al. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis Ann Surg Oncol 2012
4. G.M. Bokkerink, E.J. de Graaf, and C.J. Punt et al. The CARTS study: chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery BMC Surg 11 2011 34
5. M. Maas, R.G. Beets-Tan, and D.M. Lambregts et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer J Clin Oncol 29 2011 4633 4640
6. R. Glynne-Jones, and R. Hughes Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation Br J Surg 99 2012 897 909
7. P. Das, J.M. Skibber, and M.A. Rodriguez-Bigas et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer Cancer 109 2007 1750 1755
8. M.H. Janssen, M.C. Ollers, and R.G. van Stiphout et al. PET-based treatment response evaluation in rectal cancer: prediction and validation Int J Radiat Oncol Biol Phys 82 2012 871 876
9. R.G. van Stiphout, G. Lammering, and J. Buijsen et al. Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging Radiother Oncol 98 2011 126 133
10. K. Lu, Y. Zhu, L. Sheng, L. Liu, L. Shen, and Q. Wei Serum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancer Hepatogastroenterology 58 2011 1507 1510
11. J.W. Park, S.B. Lim, and D.Y. Kim et al. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery Int J Radiat Oncol Biol Phys 74 2009 810 817
12. S.M. Yoon, D.Y. Kim, and T.H. Kim et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 69 2007 1167 1172
13. A. Debucquoy, L. Goethals, K. Geboes, S. Roels, W.H. Mc Bride, and K. Haustermans Molecular responses of rectal cancer to preoperative chemoradiation Radiother Oncol 80 2006 172 177
14. C. Dehing-Oberije, H. Aerts, and S. Yu et al. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325) Int J Radiat Oncol Biol Phys 81 2011 360 368
15. J. Buijsen, J. van den Bogaard, and M.H. Janssen et al. FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer Radiother Oncol 98 2011 270 276
16. P.H. Anborgh, J.C. Mutrie, A.B. Tuck, and A.F. Chambers Role of the metastasis-promoting protein osteopontin in the tumour microenvironment J Cell Mol Med 14 2010 2037 2044
17. G.F. Weber, G.S. Lett, and N.C. Haubein Osteopontin is a marker for cancer aggressiveness and patient survival Br J Cancer 103 2010 861 869
18. M.J. Goldstein, and E.P. Mitchell Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer Cancer Invest 23 2005 338 351
19. D.J. Waugh, and C. Wilson The interleukin-8 pathway in cancer Clin Cancer Res 14 2008 6735 6741
20. M.A. Gordon, J. Gil, and B. Lu et al. Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation Pharmacogenomics 7 2006 67 88
21. M.F. Kalady, J.C. Coffey, K. Dejulius, A. Jarrar, and J.M. Church High-throughput arrays identify distinct genetic profiles associated with lymph node involvement in rectal cancer Dis Colon Rectum 55 2012 628 639
22. S.Y. Park, H.J. Chang, and D.Y. Kim et al. Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy? Histopathology 59 2011 650 659
23. J.G. Kuremsky, J.E. Tepper, and H.L. McLeod Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 2009 673 688
24. P. Lambin, R.G. van Stiphout, and M.H. Starmans et al. Predicting outcomes in radiation oncology-multifactorial decision support systems Nat Rev Clin Oncol 2012